Raze Therapeutics' Death

Raze Therapeutics raised a round of funding on December 14, 2017. Investors include Dead.

Raze Therapeutics is dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways essential to cancer growth and survival. By selective…

Articles about Raze Therapeutics' Death: